| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.921 | 0.002 | 0.921 | Androgen antagonist | 0.748 0.002 DBMET00500 0.576 0.003 DBMET00511 | ||
| 0.877 | 0.003 | 0.93 | Cholesterol antagonist | 0.92 0.002 DBMET00500 0.93 0.002 DBMET00511 | DBMET00511 | |
| 0.87 | 0.002 | 0.87 | Anesthetic general | 0.192 0.079 DBMET00500 0.439 0.012 DBMET00511 | ||
| 0.839 | 0.001 | 0.839 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.107 0.004 DBMET00500 0.241 0.003 DBMET00511 | ||
| 0.845 | 0.01 | 0.845 | Transcription factor NF kappa B inhibitor | 0.801 0.013 DBMET00500 0.722 0.018 DBMET00511 | ||
| 0.832 | 0.011 | 0.929 | Antiinflammatory | 0.929 0.005 DBMET00500 0.865 0.008 DBMET00511 | DBMET00500 | |
| 0.794 | 0.017 | 0.794 | Apoptosis agonist | 0.672 0.035 DBMET00500 0.679 0.034 DBMET00511 | ||
| 0.763 | 0 | 0.763 | Transcortin receptor antagonist | 0.066 0.001 DBMET00500 0.039 0.001 DBMET00511 | ||
| 0.746 | 0.018 | 0.746 | Caspase 9 stimulant | 0.254 0.248 DBMET00500 | ||
| 0.689 | 0.005 | 0.689 | Hypoxia-inducible factor 1 alpha inhibitor | 0.688 0.005 DBMET00500 0.409 0.028 DBMET00511 | ||
| 0.686 | 0.001 | 0.686 | Glucose-6-phosphate dehydrogenase inhibitor | 0.108 0.003 DBMET00500 0.217 0.002 DBMET00511 | ||
| 0.654 | 0.004 | 0.795 | Diuretic | 0.71 0.004 DBMET00500 0.795 0.003 DBMET00511 | DBMET00511 | |
| 0.643 | 0.003 | 0.643 | Neurotrophic factor enhancer | 0.183 0.095 DBMET00500 0.25 0.039 DBMET00511 | ||
| 0.635 | 0.002 | 0.635 | Aromatase inhibitor | 0.594 0.003 DBMET00500 0.519 0.003 DBMET00511 | ||
| 0.623 | 0.001 | 0.623 | Aldosterone antagonist | 0.192 0.004 DBMET00500 0.295 0.003 DBMET00511 | ||
| 0.602 | 0.004 | 0.602 | Growth factor agonist | 0.319 0.012 DBMET00511 | ||
| 0.599 | 0.004 | 0.599 | NOS3 expression enhancer | 0.256 0.025 DBMET00500 0.425 0.007 DBMET00511 | ||
| 0.579 | 0.001 | 0.579 | 5-Alpha-reductase 2 inhibitor | 0.103 0.005 DBMET00500 0.219 0.003 DBMET00511 | ||
| 0.58 | 0.003 | 0.58 | Interferon gamma antagonist | 0.487 0.007 DBMET00500 0.324 0.017 DBMET00511 | ||
| 0.586 | 0.011 | 0.586 | Apoptosis antagonist | 0.286 0.095 DBMET00500 0.358 0.052 DBMET00511 | ||
| 0.57 | 0.001 | 0.57 | 5-Alpha-reductase inhibitor | 0.302 0.003 DBMET00500 0.34 0.003 DBMET00511 | ||
| 0.578 | 0.016 | 0.624 | Immunosuppressant | 0.624 0.01 DBMET00500 0.527 0.026 DBMET00511 | DBMET00500 | |
| 0.562 | 0.004 | 0.562 | Interleukin 2 agonist | 0.437 0.018 DBMET00500 0.454 0.015 DBMET00511 | ||
| 0.547 | 0.001 | 0.547 | 5-Alpha-reductase 1 inhibitor | 0.161 0.004 DBMET00500 0.242 0.003 DBMET00511 | ||
| 0.528 | 0.002 | 0.652 | Cholesterol synthesis inhibitor | 0.601 0.001 DBMET00500 0.652 0.001 DBMET00511 | DBMET00511 | |
| 0.535 | 0.013 | 0.535 | Nitric oxide antagonist | 0.394 0.026 DBMET00500 0.429 0.022 DBMET00511 | ||
| 0.509 | 0.001 | 0.509 | Glycine receptor agonist | 0.252 0.003 DBMET00500 0.385 0.001 DBMET00511 | ||
| 0.546 | 0.038 | 0.546 | Cyclophilin D inhibitor | 0.39 0.097 DBMET00500 0.459 0.064 DBMET00511 | ||
| 0.512 | 0.008 | 0.512 | Interleukin agonist | 0.166 0.152 DBMET00511 | ||
| 0.503 | 0.001 | 0.732 | Glycine receptor antagonist | 0.595 0.001 DBMET00500 0.732 0 DBMET00511 | DBMET00511 | |
| 0.491 | 0.004 | 0.491 | Sodium/bile acid cotransporter inhibitor | 0.448 0.008 DBMET00500 0.457 0.007 DBMET00511 | ||
| 0.489 | 0.004 | 0.59 | Lipocortins synthesis antagonist | 0.59 0.002 DBMET00500 0.419 0.007 DBMET00511 | DBMET00500 | |
| 0.468 | 0.009 | 0.468 | Hepatoprotectant | 0.377 0.015 DBMET00500 0.441 0.01 DBMET00511 | ||
| 0.46 | 0.002 | 0.46 | Progesterone antagonist | 0.163 0.005 DBMET00500 0.071 0.012 DBMET00511 | ||
| 0.485 | 0.031 | 0.569 | Immunostimulant | 0.554 0.022 DBMET00500 0.569 0.02 DBMET00511 | DBMET00511 | |
| 0.452 | 0.002 | 0.88 | Androgen agonist | 0.88 0.001 DBMET00500 0.501 0.002 DBMET00511 | DBMET00500 | |
| 0.454 | 0.008 | 0.454 | Phospholipase C inhibitor | 0.294 0.019 DBMET00500 0.429 0.009 DBMET00511 | ||
| 0.453 | 0.007 | 0.453 | Amylase inhibitor | |||
| 0.446 | 0.004 | 0.446 | AMP-activated protein kinase stimulant | 0.09 0.085 DBMET00511 | ||
| 0.43 | 0.002 | 0.43 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.076 0.005 DBMET00511 | ||
| 0.463 | 0.046 | 0.463 | Antiobesity | 0.245 0.161 DBMET00500 0.415 0.06 DBMET00511 | ||
| 0.404 | 0.005 | 0.404 | Hedgehog signaling inhibitor | 0.113 0.046 DBMET00511 | ||
| 0.414 | 0.015 | 0.414 | P-glycoprotein inhibitor | 0.243 0.044 DBMET00500 0.197 0.066 DBMET00511 | ||
| 0.424 | 0.037 | 0.424 | Immunomodulator | 0.322 0.071 DBMET00500 0.375 0.052 DBMET00511 | ||
| 0.409 | 0.024 | 0.409 | Hypolipemic | 0.169 0.119 DBMET00500 0.245 0.07 DBMET00511 | ||
| 0.383 | 0.001 | 0.383 | RNA-directed RNA polymerase stimulant | 0.302 0.002 DBMET00500 0.263 0.002 DBMET00511 | ||
| 0.385 | 0.007 | 0.385 | DNA polymerase I inhibitor | 0.274 0.014 DBMET00500 0.27 0.014 DBMET00511 | ||
| 0.399 | 0.023 | 0.399 | Psychostimulant | |||
| 0.366 | 0.004 | 0.366 | Farnesoid X receptor antagonist | 0.248 0.012 DBMET00500 0.283 0.007 DBMET00511 | ||
| 0.364 | 0.002 | 0.364 | Bile acid receptor antagonist | 0.162 0.006 DBMET00500 0.298 0.003 DBMET00511 | ||
| 0.355 | 0.016 | 0.355 | Melanin inhibitor | 0.162 0.067 DBMET00500 0.127 0.121 DBMET00511 | ||
| 0.327 | 0.005 | 0.52 | Estrogen agonist | 0.52 0.003 DBMET00500 0.391 0.004 DBMET00511 | DBMET00500 | |
| 0.327 | 0.009 | 0.327 | Aldehyde dehydrogenase inhibitor | |||
| 0.318 | 0.005 | 0.318 | Estrogen antagonist | 0.229 0.01 DBMET00500 0.154 0.022 DBMET00511 | ||
| 0.352 | 0.046 | 0.462 | Antioxidant | 0.462 0.025 DBMET00500 0.393 0.036 DBMET00511 | DBMET00500 | |
| 0.31 | 0.005 | 0.31 | Estrogen receptor alpha antagonist | 0.104 0.025 DBMET00500 0.08 0.049 DBMET00511 | ||
| 0.3 | 0.001 | 0.887 | Anabolic | 0.887 0 DBMET00500 0.433 0.001 DBMET00511 | DBMET00500 | |
| 0.35 | 0.059 | 0.35 | Caspase 3 stimulant | |||
| 0.293 | 0.002 | 0.296 | Arachidonic acid antagonist | 0.296 0.002 DBMET00500 0.251 0.005 DBMET00511 | DBMET00500 | |
| 0.274 | 0.004 | 0.274 | Estrogen receptor alpha agonist | 0.24 0.004 DBMET00500 0.12 0.007 DBMET00511 | ||
| 0.27 | 0.003 | 0.27 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.145 0.005 DBMET00500 0.15 0.005 DBMET00511 | ||
| 0.309 | 0.046 | 0.634 | Angiogenesis stimulant | 0.565 0.008 DBMET00500 0.634 0.005 DBMET00511 | DBMET00511 | |
| 0.286 | 0.038 | 0.379 | Platelet adhesion inhibitor | 0.334 0.024 DBMET00500 0.379 0.014 DBMET00511 | DBMET00511 | |
| 0.253 | 0.006 | 0.253 | ABCA1 expression enhancer | 0.112 0.037 DBMET00500 0.149 0.018 DBMET00511 | ||
| 0.251 | 0.005 | 0.369 | GABA receptor antagonist | 0.088 0.019 DBMET00500 0.369 0.004 DBMET00511 | DBMET00511 | |
| 0.29 | 0.05 | 0.29 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.244 | 0.004 | 0.296 | Estrogen receptor beta agonist | 0.296 0.004 DBMET00500 0.197 0.005 DBMET00511 | DBMET00500 | |
| 0.261 | 0.021 | 0.261 | Interleukin 6 antagonist | 0.217 0.032 DBMET00500 | ||
| 0.256 | 0.019 | 0.256 | Anesthetic local | |||
| 0.253 | 0.026 | 0.277 | Lipid peroxidase inhibitor | 0.277 0.022 DBMET00500 0.196 0.043 DBMET00511 | DBMET00500 | |
| 0.223 | 0.002 | 0.223 | Na+ K+ transporting ATPase inhibitor | 0.16 0.004 DBMET00500 0.208 0.002 DBMET00511 | ||
| 0.233 | 0.016 | 0.233 | Neurotrophic factor | |||
| 0.22 | 0.004 | 0.22 | Estradiol 17 beta-dehydrogenase inhibitor | 0.048 0.026 DBMET00500 | ||
| 0.277 | 0.062 | 0.277 | Hypoglycemic | |||
| 0.269 | 0.058 | 0.269 | Gastrin inhibitor | |||
| 0.212 | 0.008 | 0.212 | Pregnane X receptor agonist | 0.141 0.07 DBMET00500 0.182 0.017 DBMET00511 | ||
| 0.213 | 0.009 | 0.213 | Estrogen receptor beta antagonist | 0.142 0.018 DBMET00500 0.118 0.034 DBMET00511 | ||
| 0.224 | 0.026 | 0.224 | Insulin secretagoues | |||
| 0.2 | 0.003 | 0.2 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.029 0.026 DBMET00500 0.035 0.019 DBMET00511 | ||
| 0.29 | 0.101 | 0.29 | Calcium channel activator | |||
| 0.193 | 0.004 | 0.193 | Mineralocorticoid receptor antagonist | 0.107 0.007 DBMET00500 0.098 0.008 DBMET00511 | ||
| 0.205 | 0.019 | 0.205 | Microtubule formation inhibitor | |||
| 0.316 | 0.13 | 0.316 | Analgesic | |||
| 0.187 | 0.002 | 0.25 | Progesterone agonist | 0.25 0.002 DBMET00500 0.123 0.003 DBMET00511 | DBMET00500 | |
| 0.212 | 0.028 | 0.212 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.255 | 0.073 | 0.354 | Tumour necrosis factor alpha release inhibitor | 0.295 0.055 DBMET00500 0.354 0.037 DBMET00511 | DBMET00511 | |
| 0.203 | 0.025 | 0.203 | Adenylate cyclase inhibitor | |||
| 0.183 | 0.006 | 0.253 | GABA A receptor antagonist | 0.058 0.032 DBMET00500 0.253 0.005 DBMET00511 | DBMET00511 | |
| 0.177 | 0.001 | 0.177 | Hedgehog signaling activator | 0.043 0.004 DBMET00500 0.052 0.003 DBMET00511 | ||
| 0.194 | 0.019 | 0.194 | GABA receptor agonist | |||
| 0.178 | 0.006 | 0.518 | Acetylcholine release stimulant | 0.213 0.004 DBMET00500 0.518 0.002 DBMET00511 | DBMET00511 | |
| 0.247 | 0.084 | 0.247 | Cardiotonic | |||
| 0.201 | 0.041 | 0.201 | Protein kinase stimulant | |||
| 0.191 | 0.032 | 0.226 | Protein-tyrosine phosphatase 1B inhibitor | 0.197 0.03 DBMET00500 0.226 0.022 DBMET00511 | DBMET00511 | |
| 0.162 | 0.004 | 0.291 | Glucocorticoid antagonist | 0.291 0.003 DBMET00500 0.102 0.005 DBMET00511 | DBMET00500 | |
| 0.162 | 0.004 | 0.162 | Liver X receptor alpha agonist | |||
| 0.232 | 0.077 | 0.232 | Free radical scavenger | |||
| 0.232 | 0.089 | 0.232 | Aldehyde oxidase inhibitor | |||
| 0.237 | 0.096 | 0.237 | 5 Hydroxytryptamine release stimulant | |||
| 0.152 | 0.012 | 0.233 | CDC25A inhibitor | 0.17 0.01 DBMET00500 0.233 0.005 DBMET00511 | DBMET00511 | |
| 0.172 | 0.033 | 0.179 | Adenylate cyclase stimulant | 0.179 0.026 DBMET00500 0.173 0.032 DBMET00511 | DBMET00500 | |
| 0.192 | 0.055 | 0.29 | Antipruritic | 0.29 0.016 DBMET00500 | DBMET00500 | |
| 0.138 | 0.004 | 0.183 | Estrone sulfatase inhibitor | 0.183 0.002 DBMET00500 0.174 0.003 DBMET00511 | DBMET00500 | |
| 0.137 | 0.002 | 0.155 | Lipocortins synthesis agonist | 0.155 0.002 DBMET00500 0.122 0.003 DBMET00511 | DBMET00500 | |
| 0.144 | 0.014 | 0.144 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.142 | 0.017 | 0.142 | GABA A receptor agonist | |||
| 0.277 | 0.153 | 0.516 | Antibacterial | 0.516 0.036 DBMET00500 0.44 0.06 DBMET00511 | DBMET00500 | |
| 0.145 | 0.022 | 0.145 | Acetylcholine nicotinic antagonist | |||
| 0.164 | 0.042 | 0.164 | Monophenol monooxygenase inhibitor | 0.152 0.046 DBMET00500 0.098 0.077 DBMET00511 | ||
| 0.128 | 0.008 | 0.128 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | |||
| 0.217 | 0.098 | 0.23 | DNA synthesis inhibitor | 0.23 0.082 DBMET00500 | DBMET00500 | |
| 0.175 | 0.059 | 0.302 | Protein-tyrosine phosphatase inhibitor | 0.268 0.026 DBMET00500 0.302 0.019 DBMET00511 | DBMET00511 | |
| 0.132 | 0.021 | 0.132 | Inducible nitric-oxide synthase inhibitor | 0.108 0.031 DBMET00500 0.129 0.021 DBMET00511 | ||
| 0.143 | 0.032 | 0.223 | Antineoplastic antibiotic | 0.223 0.017 DBMET00500 0.13 0.036 DBMET00511 | DBMET00500 | |
| 0.115 | 0.006 | 0.115 | Liver X receptor agonist | 0.039 0.037 DBMET00500 0.054 0.02 DBMET00511 | ||
| 0.136 | 0.03 | 0.165 | Toll-Like receptor 4 antagonist | 0.165 0.014 DBMET00500 | DBMET00500 | |
| 0.109 | 0.003 | 0.227 | Glucocorticoid agonist | 0.227 0.002 DBMET00500 0.066 0.003 DBMET00511 | DBMET00500 | |
| 0.127 | 0.022 | 0.127 | Transcription factor NF kappa B stimulant | 0.082 0.065 DBMET00511 | ||
| 0.107 | 0.003 | 0.107 | GABA uptake inhibitor | 0.038 0.029 DBMET00511 | ||
| 0.102 | 0.002 | 0.102 | Corticosteroid-like | 0.102 0.002 DBMET00500 0.063 0.003 DBMET00511 | ||
| 0.104 | 0.004 | 0.104 | Farnesoid X receptor agonist | 0.041 0.023 DBMET00500 0.076 0.006 DBMET00511 | ||
| 0.147 | 0.051 | 0.147 | Ca2+-transporting ATPase inhibitor | |||
| 0.143 | 0.05 | 0.219 | Alkylator | 0.219 0.021 DBMET00500 0.099 0.089 DBMET00511 | DBMET00500 | |
| 0.142 | 0.057 | 0.142 | Cholinergic antagonist | |||
| 0.139 | 0.056 | 0.139 | Acetylcholine antagonist | |||
| 0.192 | 0.112 | 0.303 | RNA-directed DNA polymerase inhibitor | 0.257 0.045 DBMET00500 0.303 0.031 DBMET00511 | DBMET00511 | |
| 0.082 | 0.006 | 0.082 | Pregnane X receptor antagonist | |||
| 0.114 | 0.043 | 0.114 | Prolactin inhibitor | |||
| 0.19 | 0.124 | 0.19 | DNA damaging | |||
| 0.081 | 0.014 | 0.081 | Heme oxygenase stimulant | 0.066 0.033 DBMET00500 0.064 0.035 DBMET00511 | ||
| 0.145 | 0.079 | 0.145 | Acetylcholine M1 receptor antagonist | |||
| 0.071 | 0.006 | 0.071 | Parathyroid hormone antagonist | |||
| 0.104 | 0.04 | 0.104 | Ornithine decarboxylase inhibitor | |||
| 0.172 | 0.109 | 0.172 | EphB2 antagonist | |||
| 0.094 | 0.033 | 0.094 | Estrogen-related receptor beta agonist | |||
| 0.134 | 0.073 | 0.134 | Bone formation stimulant | |||
| 0.168 | 0.111 | 0.168 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.09 | 0.038 | 0.09 | Keratolytic | |||
| 0.055 | 0.004 | 0.055 | Vitamin D receptor antagonist | 0.024 0.012 DBMET00511 | ||
| 0.05 | 0.007 | 0.05 | HMG CoA reductase inhibitor | |||
| 0.053 | 0.01 | 0.053 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.052 | 0.01 | 0.052 | Liver X receptor beta agonist | |||
| 0.059 | 0.016 | 0.059 | Microtubule stabilization | |||
| 0.094 | 0.052 | 0.094 | Antineoplastic alkaloid | |||
| 0.049 | 0.007 | 0.049 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.042 | 0.003 | 0.042 | Vitamin D receptor agonist | 0.016 0.013 DBMET00511 | ||
| 0.047 | 0.009 | 0.047 | Ceramide glucosyltransferase inhibitor | 0.034 0.027 DBMET00511 | ||
| 0.07 | 0.036 | 0.231 | HIV-1 integrase (Strand Transfer) inhibitor | 0.174 0.011 DBMET00500 0.231 0.007 DBMET00511 | DBMET00511 | |
| 0.113 | 0.086 | 0.113 | Cyclooxygenase 3 inhibitor | |||
| 0.105 | 0.079 | 0.105 | Photosensitizer | |||
| 0.034 | 0.009 | 0.034 | CYP24 inhibitor | |||
| 0.026 | 0.002 | 0.026 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.012 0.009 DBMET00500 0.021 0.003 DBMET00511 | ||
| 0.106 | 0.083 | 0.106 | Acetylcholine muscarinic antagonist | |||
| 0.167 | 0.147 | 0.167 | Spasmolytic | |||
| 0.037 | 0.018 | 0.037 | Tubulin agonist | |||
| 0.021 | 0.003 | 0.021 | Progesterone receptor A antagonist | |||
| 0.024 | 0.007 | 0.024 | Ileal bile acid transport inhibitor | |||
| 0.048 | 0.031 | 0.048 | Potassium channel Kv1.3 blocker | |||
| 0.022 | 0.006 | 0.022 | Telomerase stimulant | |||
| 0.091 | 0.08 | 0.091 | Expectorant | |||
| 0.06 | 0.05 | 0.06 | CDC25B inhibitor | |||
| 0.178 | 0.171 | 0.178 | Transcription factor STAT inhibitor | |||
| 0.04 | 0.034 | 0.04 | Opioid kappa receptor agonist | |||
| 0.021 | 0.018 | 0.021 | Prostaglandin F2 alpha agonist | |||
| 0.048 | 0.045 | 0.048 | Acetylcholine M2 receptor agonist | |||
| 0.004 | 0.003 | 0.004 | Vitamin D-like | |||
| 0.024 | 0.036 | 0.033 | 1,3-Beta-glucan synthase inhibitor | 0.032 0.011 DBMET00500 0.033 0.009 DBMET00511 | DBMET00511 | |
| 0.055 | 0.068 | 0.092 | Neuraminidase (influenza) inhibitor | 0.081 0.024 DBMET00500 0.092 0.019 DBMET00511 | DBMET00511 | |
| 0.046 | 0.073 | 0.137 | HIV-1 integrase (3'-Processing) inhibitor | 0.115 0.021 DBMET00500 0.137 0.015 DBMET00511 | DBMET00511 | |
| 0.098 | 0.137 | 0.169 | Thrombolytic | 0.169 0.069 DBMET00500 0.16 0.075 DBMET00511 | DBMET00500 | |
| 0.086 | 0.138 | 0.104 | Interleukin 8 antagonist | 0.104 0.088 DBMET00500 | DBMET00500 | |
| 0.161 | 0.234 | 0.335 | Antithrombotic | 0.306 0.084 DBMET00500 0.335 0.07 DBMET00511 | DBMET00511 | |
| 0.033 | 0.113 | 0.079 | Heparanase inhibitor | 0.059 0.025 DBMET00500 0.079 0.007 DBMET00511 | DBMET00511 | |
| 0.018 | 0.099 | 0.037 | Toll-Like receptor 4 agonist | 0.031 0.01 DBMET00500 0.037 0.006 DBMET00511 | DBMET00511 | |
| 0.048 | 0.131 | 0.196 | NMDA receptor antagonist | 0.076 0.071 DBMET00500 0.196 0.015 DBMET00511 | DBMET00511 | |
| 0.027 | 0.115 | 0.057 | Neuraminidase inhibitor | 0.057 0.047 DBMET00511 | DBMET00511 | |
| 0.084 | 0.232 | 0.203 | Hemostatic | 0.198 0.033 DBMET00500 0.203 0.031 DBMET00511 | DBMET00511 | |
| 0.049 | 0.215 | 0.086 | Protein kinase C zeta inhibitor | 0.086 0.072 DBMET00511 | DBMET00511 | |
| 0.031 | 0.255 | 0.071 | Adenine nucleotide translocase inhibitor | 0.071 0.014 DBMET00500 0.071 0.014 DBMET00511 | DBMET00511 | |
| 0.058 | 0.283 | 0.193 | Cell wall synthesis inhibitor | 0.193 0.033 DBMET00500 0.142 0.073 DBMET00511 | DBMET00500 | |
| 0.008 | 0.245 | 0.205 | NMDA 2D receptor antagonist | 0.158 0.003 DBMET00500 0.205 0.003 DBMET00511 | DBMET00511 | |
| 0.096 | 0.342 | 0.481 | Angiogenesis inhibitor | 0.481 0.033 DBMET00500 0.397 0.054 DBMET00511 | DBMET00500 | |
| 0.014 | 0.268 | 0.235 | Selectin antagonist | 0.211 0.01 DBMET00500 0.235 0.009 DBMET00511 | DBMET00511 | |
| 0.015 | 0.274 | 0.572 | NMDA 2B receptor antagonist | 0.564 0.003 DBMET00500 0.572 0.003 DBMET00511 | DBMET00511 | |
| 0.04 | 0.371 | 0.115 | Cell adhesion inhibitor | 0.115 0.069 DBMET00511 | DBMET00511 | |
| 0.005 | 0.341 | 0.103 | NMDA 2 receptor antagonist | 0.103 0.03 DBMET00500 0.093 0.036 DBMET00511 | DBMET00500 | |
| 0.021 | 0.556 | 0.19 | Dual specificity phosphatase inhibitor | 0.138 0.108 DBMET00500 0.19 0.06 DBMET00511 | DBMET00511 | |
| 0.008 | 0.591 | 0.11 | Glutamate receptor antagonist | 0.11 0.085 DBMET00511 | DBMET00511 | |
| 0.015 | 0.614 | 0.184 | Dual specificity phosphatase 3 inhibitor | 0.13 0.117 DBMET00500 0.184 0.07 DBMET00511 | DBMET00511 | |
| 0.014 | 0.643 | 0.177 | Multidrug resistance-associated protein 1 inhibitor | 0.176 0.016 DBMET00500 0.177 0.016 DBMET00511 | DBMET00511 | |
| 0.008 | 0.701 | 0.291 | Cholecystokinin B agonist | 0.249 0.004 DBMET00500 0.291 0.003 DBMET00511 | DBMET00511 | |
| 0.007 | 0.789 | 0.29 | Anticoagulant | 0.239 0.041 DBMET00500 0.29 0.03 DBMET00511 | DBMET00511 | |
| 0.002 | 0.803 | 0.027 | Cholecystokinin B antagonist | 0.027 0.024 DBMET00511 | DBMET00511 | |
| 0.011 | 0.826 | 0.087 | Factor IXa inhibitor | 0.076 0.018 DBMET00500 0.087 0.013 DBMET00511 | DBMET00511 | |
| 0.002 | 0.88 | 0.045 | Cholecystokinin A antagonist | 0.045 0.022 DBMET00511 | DBMET00511 | |
| 0.002 | 0.948 | 0.127 | Cholecystokinin agonist | 0.102 0.004 DBMET00500 0.127 0.004 DBMET00511 | DBMET00511 | |
| 0.002 | 0.962 | 0.108 | Cholecystokinin A agonist | 0.082 0.004 DBMET00500 0.108 0.004 DBMET00511 | DBMET00511 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |